An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations
NCT06913725
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Brain Arteriovenous Malformations
Interventions
DRUG:
FCN-159
Sponsor
Xuanwu Hospital, Beijing
Collaborators
[object Object]